
Quick and effective access to treatment is the key
The Centers for Disease Control and Prevention (CDC) recommends antiretroviral therapy (ART) for the human immunodeficiency virus (HIV). Antiretrovirals reduce viral mortality at any stage of infection, reduce transmission, and maintain a high CD4 cell count.
Photo: Iniciativa Comunitaria
ANTIRETROVIRALS (ARV)
HIV medications, also known as antiretrovirals, slow the progression of the virus in the body. It is recommended that everyone living with HIV begin treatment to improve and stabilize their health. The usual treatment is one pill a day, every day.
RAPID INITIATION
According to the World Health Organization, rapid HIV treatment initiation is defined as starting antiretroviral (ARV) treatment within the first seven (7) days of diagnosis. Rapid linkage to antiretroviral treatment is essential for achieving an undetectable viral load (<200 copies/ml) in a significantly shorter period of time.
ā
This allows for:
-
Reducing the amount of HIV in the blood (viral load)
-
Reaching an undetectable and untransmissible status
-
Maintaining high levels of CD4 cells (a type of white blood cell)
-
Reducing the risk of transmitting the virus to sexual partners
-
Maintaining a healthy life
-
Preventing illnesses
-
Prolonging life expectancy
-
Preventing Acquired Immunodeficiency Syndrome (AIDS)
EFFECTIVE TREATMENT
It's important to talk to a healthcare professional about strategies for maintaining effective HIV treatment. Discuss adherence tools and talk about how treatment can prevent transmission of the virus to sexual partners. Continue using condoms correctly and consistently, and take your medications daily as prescribed.
References
Centers for Disease Control and Prevention. (2020). How to Optimize HIV Treatment. Retrieved from: https://www.cdc.gov/hiv/clinicians/treatment/treatment-clinicians.html
HIV.gov. (2021). HIV Treatment Overview. Retrieved from: https://www .hiv .gov/hiv-basics/staying-in-hiv-care/hiv-treatment/hiv-treatment-overview
ā
World Health Organization. (2017). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: WHO. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK475977/.
ā
Note: This brochure is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a total grant of $4,856,532, with 0% funded from non-governmental sources. The content belongs to the authors and does not necessarily represent the official views or endorsement of HRSA, HHS, or the U.S. Government.
Nota: Este folleto cuenta con el respaldo de la Administración de Recursos y Servicios de Salud (HRSA, por sus siglas en inglés) del Departamento de Salud y Servicios Humanos (HHS, por sus siglas en inglés) de los EE. UU. Como parte de una subvención total de $4,856,532.00 con 0 % financiamiento con fuentes no gubernamentales. El contenido le pertenece a los autores y no representa necesariamente la opinión oficial ni el respaldo de HRSA, HHS o el Gobierno de los EE. UU.āā



